Ariosa Diagnostics
Ariosa Diagnostics is a molecular diagnostics company focused on improving patient care.
Funding reportedLast round: Series C
Follow Ariosa Diagnostics and see its new rounds in your feed.Start following
What company datasets say Ariosa Diagnostics raised
Funding, as reported
Reported in all67.5Min the source's currency
Rounds3
Last roundSeries C
Last round dateJan 2012
Investors listed3
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Ariosa Diagnostics in front of investors. Or tell us what we have wrong.